|Bid||301.95 x 1300|
|Ask||313.38 x 800|
|Day's Range||301.73 - 309.40|
|52 Week Range||196.78 - 404.20|
|Beta (5Y Monthly)||1.11|
|PE Ratio (TTM)||70.46|
|Earnings Date||Jan 27, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||296.47|
Dr. Charles Kennedy, CEO of Blue Ox Healthcare Partners, answers Barron’s readers’ questions on health-care innovation, delivery, and investing.
Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.
Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.